10/4/24 19:40 | 10/2/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
6/15/23 20:13 | 6/14/23 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 6 | 0.2149 | 0 | 30 | 6 | 563 | D | | | | | | | | | | | | | | |
4/7/23 17:12 | 4/5/23 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I | | | | | | | | | | | | | | |
4/5/23 21:35 | 4/3/23 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 8,094 | 0.3017 | 0 | 26,828 | 36 | 100,366 | M | | | | | | | | | | | | | | |
12/28/22 16:05 | 12/23/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 88 | 0.3515 | 0 | 250 | 80 | 562 | D | | | | | | | | | | | | | | |
12/28/22 16:05 | 12/23/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | | P | 25 | 0.3297 | 0 | 75 | New | 75 | I | | | | | | | | | | | | | | |
12/27/22 18:47 | 12/22/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 7 | 0.2850 | 0 | 25 | 5 | 533 | D | | | | | | | | | | | | | | |
8/19/22 08:00 | 8/17/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Last Andrew J. | CA | D | | P | 17 | 0.8700 | 0 | 20 | 40 | 70 | D | | | | | | | | | | | | | | |
8/19/22 08:00 | 8/17/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 14 | 0.9000 | 0 | 15 | New | 15 | I | | | | | | | | | | | | | | |
8/18/22 16:05 | 8/16/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Andrews Ronald Asbury | CA | DO | P,CEO | P | 38 | 0.9600 | 0 | 40 | 14 | 333 | D | | | | | | | | | | | | | | |
8/17/22 20:20 | 8/15/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P.d | 10 | 0.9700 | 0 | 10 | 2 | 508 | D | | | | | | | | | | | | | | |
8/17/22 20:19 | 8/15/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | | P.d | 23 | 0.9300 | 0 | 25 | 250 | 35 | M | | | | | | | | | | | | | | |
8/17/22 20:18 | 8/16/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Griffith Melinda | CA | D | | P.d | 10 | 1.00 | 0 | 10 | 50 | 30 | D | | | | | | | | | | | | | | |
8/17/22 20:17 | 8/16/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Carter Jennifer L. | CA | D | | P.d | 10 | 0.9500 | 0 | 11 | 53 | 31 | D | | | | | | | | | | | | | | |
8/17/22 20:15 | 8/15/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P.dm | 144 | 0.9608 | 0 | 150 | 114 | 282 | D | | | | | | | | | | | | | | |
6/28/22 19:46 | 4/14/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.a | 250 | 1.25 | 0 | 200 | 1 | 16,006 | I | | | | | | | | | | | | | | |
4/29/22 16:33 | 4/14/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.ad | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | | | | | | | | | | | | | | |
4/18/22 21:55 | 4/14/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.d | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | | | | | | | | | | | | | | |
4/15/22 18:13 | 4/14/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 8,000 | 1.33 | 0 | 6,004 | 15 | 46,711 | M | | | | | | | | | | | | | | |
3/28/22 20:00 | 3/25/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ross Douglas T. | CA | O | Chief Sc | P | 21 | 1.40 | 0 | 15 | 282 | 20 | D | | | | | | | | | | | | | | |
3/17/22 21:27 | 3/17/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Paulsen Gisela | CA | O | COO | P.d | 20 | 1.20 | 0 | 17 | New | 17 | D | | | | | | | | | | | | | | |
3/17/22 21:26 | 3/16/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Andrews Ronald Asbury | CA | DO | CEO | P | 64 | 1.28 | 0 | 50 | 21 | 293 | D | | | | | | | | | | | | | | |
3/16/22 21:08 | 3/16/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Redmond Cavan M. | CA | D | | P | 48 | 1.19 | 0 | 40 | 56 | 111 | D | | | | | | | | | | | | | | |
3/15/22 16:19 | 3/15/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Levine Mitchell S | CA | O | CFO | P | 29 | 1.17 | 0 | 25 | 40 | 87 | D | | | | | | | | | | | | | | |